Repligen Corp. (RGEN)
NGS · Common · CUSIP 759916109
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for RGEN and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
759916109
Market Cap
Large Cap
Business: Repligen Corporation is a life sciences company focused on the development and commercialization of high-value consumable products used in the process of manufacturing biological drugs. Their bioprocessing products are sold to major life sciences and biopharmaceutical companies worldwide. They are the leading manufacturer of Protein A affinity ligands, a critical component of Protein A media that is used to separate and purify monoclonal antibody therapeutics. Their ATF (Alternating Tangential Flow) System and their growth factor products are used to increase product yield during the fermentation stage of biologic drug manufacturing. In addition, they developed and market an innovative line of "ready-to-use" chromatography columns under their OPUS brand (Open-Platform User-Specified) that they deliver prepacked with their customers’ choice of purification media. Repligen’s corporate headquarters are in Waltham, MA and their manufacturing facilities are located in Waltham, MA and Lund, Sweden.
Notes: 781.419.1881

Company Contact

CEO
Olivier Loeillot
CFO
Jason K. Garland
Headquarters
41 Seyon Street, Building #1, Suite 100, Waltham, MA 02453
Phone
781-250-0111 · Toll-Free 800-622-2259
Fax
781-250-0115
Investor Relations
Sondra S. Newman · 781-419-0204 · investors@repligen.com
SEC EDGAR Filings
View filings »